SCHEMBL11680201

SCHEMBL11680201

O=C(O)c1ccc2[nH]c3c(c2c1)CCC(C(=O)O)C3

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
SIRT1 Q96EB6 2/20 0.57
MAPT P10636 2/20 0.54
POLB P06746 1/20 0.54
HSD17B10 Q99714 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
HTR1B P28222 3/20 0.49
MEN1 O00255 2/20 0.46
PARP1 P09874 1/20 0.46
HTR1A P08908 2/20 0.46
HTR1D P28221 1/20 0.46
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11679593 0.90 SIRT1 (0.55) KMT2ASIRT1MAPTPOLBHSD17B10
SCHEMBL11680918 0.85 SIRT1 (0.58) KMT2ASIRT1DRD2MAPKAPK2
SCHEMBL1874857 0.84 SIRT1 (0.79) KMT2ASIRT1MAPTHSD17B10ALDH1A1
SCHEMBL1869208 0.84 SIRT1 (0.79) SIRT1MAPKAPK2
SCHEMBL11680074 0.84 SIRT1 (0.57) KMT2ASIRT1MAPTPOLBHSD17B10
SCHEMBL11681778 0.84 SIRT1 (0.57) KMT2ASIRT1DRD2MAPKAPK2
SCHEMBL11679707 0.84 SIRT1 (0.57) KMT2ASIRT1HSD17B10L3MBTL1KDM4E
SCHEMBL11679003 0.84 MEN1 (0.67) KMT2ASIRT1MAPTPOLBHSD17B10
SCHEMBL11680034 0.83 SIRT1 (0.77) SIRT1MAPKAPK2
SCHEMBL11680029 0.83 SIRT1 (0.77) SIRT1MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4009181-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIRHEUMATIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1977-02-22 US disclosed